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ABSTRACT
The aim of this study was to determine the optimal stage of development at which transplant hu-
man ex vivo-produced oral mucosa equivalents (EVPOMEs) in vivo. EVPOMEs were generated in
a serum-free culture system, without the use of an irradiated xenogeneic feeder layer, by seeding
human oral keratinocytes onto a human cadaveric dermal equivalent, AlloDerm. EVPOMEs were
cultured for 4 days submerged and then for 7 or 14 days at an air–liquid interface to initiate strat-
ification before transplantation into SCID mice. AlloDerm, without epithelium, was used as a con-
trol. Mice were killed on days 3, 10, and 21 posttransplantation. Epithelium of the transplanted
EVPOMEs was evaluated with the differentiation marker keratin 10/13. Dermal microvessel in-
growth was determined by immunohistochemistry with a mouse vascular marker, lectin binding
from Triticum vulgaris. The presence and stratification of the epithelium were correlated with revas-
cularization of the underlying dermis. The microvessel density of AlloDerm without epithelium was
less than that of EVPOMEs with an epithelial layer. Microvessel density of the dermis varied di-
rectly with the degree of epithelial stratification of the EVPOMEs. The EVPOMEs cultured at an
air–liquid interface for 7 days had the optimal balance of neoangiogenesis and epithelial differenti-
ation necessary for in vivo grafting.
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INTRODUCTION
SINCE O’CONNOR AND OTHERS1 first reported the use ofcultured autologous epithelial sheets in patient care,
there have been numerous clinical trials to study the treat-
ment of large wounds with cultured epidermal cell
sheets.2–4 These investigators reported that cultured au-
tografts of keratinocytes had persistent problems, which
included blistering, wound contracture, susceptibility to
infection, and varying graft “take” rate. The problems
were most likely due to the lack of a dermal component
and of a mature dermoepidermal junction.5,6 To over-
come these adverse events, artificial dermal substitutes
have been used to assist in keratinocyte growth.7–12 One
dermal analog used for treatment of full-thickness
wounds is an acellular human cadaver dermis, AlloDerm
(LifeCell, Branchburg, NJ).
AlloDerm is a durable acellular dermis, which retains
extracellular matrix proteins and an intact basement
membrane structure, while being surgically manageable.
Several investigations have reported on the use of either
AlloDerm or deepidermized human dermis in the devel-
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opment of reconstituted skin and oral mucosa.13–17 We
reported on the characteristics of an ex vivo-produced
oral mucosa equivalent (EVPOME) utilizing AlloDerm
in a serum-free, defined medium, without an irradiated
xenogeneic feeder layer.18
In preparation for human clinical trials it was neces-
sary to optimize the culture protocol for the in vivo graft-
ing of EVPOME. In this investigation, we evaluated
EVPOME by transplanting it into immunologically com-
promised (SCID, severe combined immunodeficient)
mice, using the technique of Barrandon et al.,19 which
places the graft into a subcutaneous dorsal skin pouch of
athymic mice. The revascularization process that occurs
at the recipient transplantation site is a main predictor of
free graft survival. Thus, the main objective of this in-
vestigation was to correlate epithelial cell viability, strat-
ification, and differentiation with vascular ingrowth (mi-
crovessel density) into the underlying dermal component,
AlloDerm, to determine the optimal time necessary to
culture EVPOME, in vitro, before grafting into the oral
cavity.
MATERIALS AND METHODS
Production of ex vivo-produced oral 
mucosa equivalent
Cultures of human oral mucosa keratinocytes and ex
vivo production of oral mucosa equivalents (EVPOMEs)
were generated in a serum-free culture system without
the use of an irradiated xenogeneic feeder layer, as de-
scribed previously.18 Briefly, human oral keratinocytes
were generated and amplified from trypsinized discarded
human oral mucosa obtained by routine dentoalveolar
surgical procedures. AlloDerm (LifeCell) was rehydrated
in phosphate-buffered saline (PBS) 1 h before use. Har-
vested and expanded human oral keratinocytes, cultured
in a 0.15 mM Ca21, serum-free MCDB-153 complete
medium, supplemented with hydrocortisone, insulin, epi-
dermal growth factor (EGF), and bovine pituitary extract,
were seeded at a density of 1.25 3 105 keratinocytes per
square centimeter onto rehydrated AlloDerm coated with
type IV collagen (Life Technologies, Gaithersburg, MD).
The keratinocyte–AlloDerm composites were cultured
submerged in 1.8 mM Ca21-supplemented MCDB-153
complete medium for 4 days (D4E) and then at an air–
liquid interface for an additional 7 days (D11E) or 14
days (D18E) to enhance stratification of the epithelial
layer of the EVPOMEs before grafting onto SCID mice.
Only primary cells, from the first passage, were used to
fabricate the EVPOMEs for surgical transplantation into
mice. Each of the three transplantation groups received
primary donor cells from two individuals. This allowed
the generation of sufficient primary oral keratinocytes to
perform each of the three experiments in this investiga-
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tion. The three donors used to fabricate the EVPOME
grafts were two females, 62 and 64 years old, and a 55-
year-old male.
Transplantation of ex vivo-produced oral mucosa
equivalent into SCID mice
The University of Michigan Committee on Use and
Care of Animals approved all animal studies. The grafts
were transplanted into dorsal subcutaneous pouches made
in 7- to 8-week-old SCID mice, strain C.B-17/IcrTac-
scidfDF (Taconic, Germantown, NY). Mice were anes-
thetized by inhalation anesthesia (methoxyflurane [Meto-
fane]; Pittman-Moore, Mundelein, IL). The dorsal skin
of mice was disinfected with 95% ethanol. A full-thick-
ness curvilinear incision was made down to the pan-
niculus carnosus to create a subcutaneous pouch approx-
imately 1.5 to 2.0 cm2 in size to accommodate the
1.0-cm2 equivalents. Grafts were transferred to a subcu-
taneous pouch and overlaid with a circular piece of gas-
sterilized biomedical-grade silicone sheeting, 0.005 in.
thick (Specialty Manufacturing, Saginaw, MI) to prevent
adherence of the epithelial layer of the EVPOME to the
overlying connective tissue of the subcutaneous pouch.
The open reticular portion of the AlloDerm of the
EVPOME was grafted face down toward the muscular
fascia. AlloDerm, without an epithelial layer, was used
as a control. Experimental groups consisted of day 4, 11,
and 18 equivalents (D4E, D11E, and D18E, respectively).
Mice were killed on days 3, 10, and 21 postgrafting. Five
AlloDerm controls (no epithelial layer) and 15 D4E mice
were killed on each of postgrafting days 3, 10, and 21
whereas 10 mice were killed 3, 10, and 21 days post-
grafting for the D11E and D18E EVPOMEs (Table 1).
Histology and immunohistochemistry
Retrieved EVPOMEs were fixed with 10% formalin
and embedded in paraffin for histologic examination.
Specimens were cut into 5-mm sections and stained 
with hematoxylin and eosin. Immunostaining for keratin
10/13, a differentiation marker, was performed with
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TABLE 1. NUMBER OF SCID MICE USED FOR EACH TIME
POINT IN EVPOME IN VIVO GRAFTING PROTOCOL
Days postgrafting
Type of graft 3 10 21
Controla 5 5 5
Day 4 equivalent (D4E) 15 15 15
Day 11 equivalent (D11E) 10 10 10
Day 18 equivalent (D18E) 10 10 10
Abbreviation: EVPOME, Ex vivo-produced oral mucosa
equivalent.
aAlloDerm with no epithelial layer.
avidin–biotin–peroxidase complex (ABC) as described
previously.18
For detection of mouse vascular endothelial cells, im-
munohistochemical staining for Triticum vulgaris (wheat
germ agglutinin, WGA) lectin binding was used to de-
termine revascularization by counting the number of mi-
crovessels within the dermal component.20 Sections were
first treated with 2% hydrogen peroxide in methanol for
30 min to inhibit endogenous peroxidase, followed by
10% bovine serum albumin (BSA; Sigma, St. Louis, MO)
for 1 h. The sections were then incubated with biotinyl-
ated WGA antibody (Sigma), diluted 1:20 in 1% BSA,
for 1 h at 37°C and washed in phosphate-buffered saline
(PBS), followed by the ABC method (Vector Laborato-
ries, Burlingame, CA) for 10 min. A solution of peroxi-
dase substrate 3,39-diaminobenzidine tetrahydrochloride
was used for visualization of the resulting complex. The
specificity of the immunoreactants was assessed by re-
placement of biotinylated WGA with sugar or PBS.
Evaluation of vascularity and statistical analysis
To evaluate revascularization in each sample WGA
lectin immunohistochemistry was used to assist in quan-
tifying the number of invading endothelial cells. Because
single endothelial cells as well as some fibroblasts and
macrophages were immunopositive for WGA, only lu-
mens encircled by immunopositive cells were used to
identify microvessel density that is indicative of neoan-
giogenesis and revascularization of the AlloDerm. In ac-
cordance with the protocol used by Weidner et al.,21 the
highest number of vessel lumens within any 3200 field
was represented as the vessel count of the sample. Com-
parisons between groups were evaluated by a Mann–
Whitney U test. Values of p , 0.05 were considered to
be statistically significant.
RESULTS
Histologic analysis of EVPOME
In vitro
AlloDerm grafts without epithelium consisted of dense
collagen fibrils and an undulating papillary surface (Fig.
1a). AlloDerm grafts with epithelium (EVPOME) formed
a continuous keratinocyte monolayer when cultured for
4 days submerged (D4E; Fig. 1b). When the D4E grafts
were raised to an air–liquid interface for 7 days (D11E)
the epithelial layer began to stratify and show evidence
of parakeratinization (Fig. 1c). After 14 days at an air–
liquid interface (D18E) there was a continued increase in
stratification and differentiation of the epithelium (Fig.
1d). Keratin 10/13, a differentiation marker, usually ex-
pressed by cells in the suprabasal layer of oral mucosa,
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was not expressed in D4E or D11E (Fig. 2a and b). In
D18E it was visible only in the superficial layer (Fig. 2c).
Grafting to SCID mice
AlloDerm without epithelium. In the control AlloDerm
graft, without an epithelial layer, at 3 days postgrafting
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FIG. 1. Histologic findings of unseeded acellular dermis, Al-
loDerm, and ex vivo-produced oral mucosa equivalents before
transplantation. (a) Rehydrated acellular AlloDerm with dense
collagen bundles. (b) Epithelial monolayer of D4E. (c) Increase
in epithelial stratification of D11E and (d) D18E after cultur-
ing at an air–liquid interface for 7 and 14 days, respectively.
(Hematoxylin and eosin staining; original magnification, 3250;
scale bar, 50 mm.)
in vivo, a few spindle-shaped cells, similar to fibroblasts
and/or endothelial cells, were seen infiltrating into the
portion of the AlloDerm that was in direct contact with
the underlying muscular layer (Fig. 3a). Cellular infil-
tration into the AlloDerm gradually increased in number
in day 10 and 21 postgrafting transplants, but was local-
ized at the base (Fig. 3b and c). At postgrafting day 21
there was evidence of infiltrating cells present in the 
superficial or upper portion of the AlloDerm; however,
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vascularization was scarcely seen at the base or lower
portion.
Day 4 equivalent. The epithelial monolayer of grafted
D4E began to stratify at postgrafting day 3 (Fig. 4a). At
day 3 postgrafting the D4E showed an increase in the
number of fibroblasts and endothelial cells infiltrating
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FIG. 2. Immunohistologic findings of ex vivo-produced oral
mucosa equivalents before transplantation. Keratin 10/13 ex-
pression is not seen in (a) D4E or in (b) D11E. (c) In D18E, it
is present only in the superficial layer (arrows). (Original mag-
nification, 3300; scale bar, 50 mm.)
FIG. 3. Histologic analysis of grafted AlloDerm without an
epithelial layer: Postgrafting day 3 (a), day 10 (b), and day 21
(c). Cells infiltrating into the AlloDerm gradually increased in
number at the base of the dermis from day 3 to day 21 post-
grafting transplants (a–c). By postgrafting day 21 (c) there was
evidence of infiltrating cells present in the superficial or upper
portion of the AlloDerm, but vascularization was scarcely evi-
dent. M, Underlying muscle layer. (Hematoxylin and eosin
staining; original magnification, 3250; scale bar, 50 mm.)
throughout the underlying AlloDerm, in contrast to the
AlloDerm control (Fig. 4b). At postgrafting day 10 ep-
ithelial stratification and differentiation continued to in-
crease in D4E and was comparable to what was seen in
vitro in pregrafted D18E (Fig. 4c; compare with Fig. 1d).
Infiltrating spindle-shaped fibroblasts and a rounder cell
infiltration, indicative of revascularization, were more
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prominent within the lower or basal portion of the der-
mis in D4E at 10 days postgrafting when compared with
AlloDerm controls (Fig. 4d). At day 21 postgrafting, the
epithelium of D4E continued to stratify (Fig. 4e). This
directly correlated with an increase in cell infiltration and
associated revascularization within the dermis over the
day 10 postgrafting specimens (Fig. 4f ).
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FIG. 4. Histologic analysis of grafted D4E: Postgrafting day 3 (a and b), day 10 (c and d), and day 21 (e and f ); epithelial
layer (a, c, and e) and dermal portion (b, d, and f ) of grafted equivalents. The epithelial monolayer of D4E, immediately after
grafting, continues to stratify over time from day 3 to day 21 (a, c, and e). Cellular ingrowth throughout the dermis is rapid com-
pared with controls, as seen by evidence of infiltrating spindle-shaped and rounder cells at days 3 and 10 postgrafting (b and d).
At day 21 after grafting, numerous blood vessels, filled with erythrocytes, are seen within loosely arranged and disorganized col-
lagen bundles at the base of the dermis (f ). M, Underlying muscle layer. (Hematoxylin and eosin staining; original magnifica-
tion, 3250; scale bar, 50 mm.)
Day 11 equivalent. The epithelial layer of D11E, at
postgrafting days 3 and 10, continued to stratify and dif-
ferentiate (Fig. 5a and c). An increase in fibroblastic and
endothelial cell infiltration was seen at the dermal–
muscle interface at day 3 postgrafting (Fig. 5b). A
marked increase in cellular infiltration and revascular-
ization throughout the entire dermis was seen at day 10
postgrafting (Fig. 5c and d). The infiltration and revas-
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cularization were more pronounced than observed in D4E
at similar time intervals postgrafting. At day 21 post-
grafting the highly keratinized and stratified epithelial
layer showed signs of degeneration (Fig. 5e). The break-
down in the epithelial layer in D11E coincided with a de-
crease in the cellular infiltration and vascularity within
the dermis subjacent to the epithelium but cellular infil-
tration was still evident, however, within the basal or
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FIG. 5. Histologic analysis of grafted D11E: Postgrafting day 3 (a and b), day 10 (c and d), and day 21 (e and f ); epithelial
(a, c, and e) and dermal (b, d, and f ) portions of the grafted equivalents. The thin epithelial layer continued to stratify and dif-
ferentiate at day 3 postgrafting (a) and peaked in stratification at day 10 postgrafting (c). Numerous plump fibroblasts appear
subjacent to the epithelial layer at day 10 postgrafting (c). A large number of microvessels are observed within the lower por-
tion of the dermis (d). At day 21 postgrafting, the stratified and highly keratinized epithelial layer begins to show signs of de-
generation (e). In the dermal component there is a random arrangement of the collagen bundles associated with adipose-like tis-
sue (f ). M, Underlying muscle layer. (Hematoxylin and eosin staining; original magnification, 3250; scale bar, 50 mm.)
lower portion of the dermis with evidence of lumenous
structures (Fig. 5f).
Day 18 equivalent. D18E, at 3 days postgrafting,
showed signs of marked keratinization and degeneration
of the epithelial layer (Fig. 6a). This correlated with a
marked increase in fibroblastic and endothelial cell infil-
tration seen at the inferior and superior portions of the
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dermis (Fig. 6b). At day 10 postgrafting, D18E epithe-
lium continued to break down (Fig. 6c). The cellular in-
filtration and revascularization of the entire dermis con-
tinued to show a marked increase at day 10 postgrafting
(Fig. 6c and d). Arrangement of the collagen fibrils within
the dermis appeared less eosinophilic and random in na-
ture. These findings were greater than seen in D4E but
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FIG. 6. Histologic analysis of grafted D18E: Postgrafting day 3 (a and b), day 10 (c and d), and day 21 (e and f ); epithelial
(a, c, and e) and dermal (b, d, and f ) portions of the grafted equivalents. At 3 days postgrafting there was evidence of a well-
differentiated highly keratinized epithelial layer with signs of degeneration (a) associated with a cellular infiltration throughout
the dermis (b). Epithelial degeneration continues to increase at day 10 postgrafting (c). Revascularization and disorganized col-
lagen bundles of the dermis at day 10 postgrafting are evident within the lower portion of the dermis to the level seen in D11E
(d). At day 21 postgrafting, the dermal matrix demonstrates linear arrays of dense collagen bundles with evidence of adipose-
like tissue and marked vascularity present at base of the dermis (f ). M, Underlying muscle layer. (Hematoxylin and eosin stain-
ing; original magnification, 3250; scale bar, 50 mm.)
the same as was seen in D11E at day 10 postgrafting. At
day 21 postgrafting there were remnants of necrotic ep-
ithelium (Fig. 6e). Although lumenous structures, cellu-
lar infiltration, and revascularization were noted within
the dermis the histologic appearance of collagen bundles
appeared to be tighter and denser (Fig. 6f).
Immunohistochemical staining for keratin 10/13. Im-
munohistochemical detection of keratin 10/13 was used
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to determine the differentiated state of the epithelium af-
ter grafting in both the D4E (Fig. 7a, c, and e) and D11E
(Fig. 7b, d, and f ) grafted EVPOMEs at day 3, 10, and
21 days postgrafting, respectively. No evidence of ker-
atin 10/13 was observed in D4E at postgrafting day 3
(Fig. 7a); however, expression of keratin 10/13 in D11E
was seen in the superficial layer (Fig. 7b). As the ep-
ithelial layers of D4E and D11E continued to stratify at
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FIG. 7. Immunohistochemical analysis for the epithelial differentiation marker keratin 10/13 of grafted equivalents D4E and
D11E: D4E (a, c, and e) and D11E (b, d, and f ). At postgrafting day 3 (a and b), there was no evidence for staining for keratin
10/13 in D4E (a), whereas the superficial layer showed keratin 10/13 expression in D11E (b) (arrows). At day 10 (c and d) and
day 21 (e and f ) keratin 10/13 expression (arrows) increased as the epithelium continued to stratify. Expression of keratin 10/13
within the stratified epithelium in the D4E (c) was more prominent than seen in D11E (d) at day 10 postgrafting. (Immunos-
taining for keratin 10/13; original magnification, 3300; scale bar, 50 mm.)
10 and 21 days postgrafting they started to show an in-
crease in expression of keratin 10/13 when compared
with pregrafting and day 3 postgrafting equivalents (Fig.
7b–e). Expression of keratin 10/13 within the stratified
epithelium in D4E (Fig. 7c) was more prominent than
was seen in D11E (Fig. 7d) at day 10 postgrafting.
Microvessel density
WGA lectin binding allowed us to identify and count
microvessels irrespective of the presence of erythrocytes
within the lumen (Fig. 8). At day 3 postgrafting D18E
showed a significant increase (p , 0.05) in the number
of microvessels present in the dermis over the other
groups, that is, D4E, D11E, and the AlloDerm without
epithelium. At 10 days postgrafting, D4E, D11E, and
D18E all showed significantly more microvessels 
(p , 0.05) than AlloDerm without epithelium. Both
D11E and D18E 10 days postgrafting showed signifi-
cantly more microvessels (p , 0.05) when compared
with D4E 10 days postgrafting. D4E continued to in-
crease at 21 days postgrafting with a precipitous drop in
the number of microvessels present in both the D11E and
D18E 21 days postgrafting, which correlated with the de-
generation of the epithelial layer (Table 2).
DISCUSSION
In vivo animal studies utilizing sheets of oral ker-
atinocytes or full thickness mucosa grafts require an en-
vironment that will simulate that which is seen within the
oral cavity, a moist wet-surfaced epithelium. Barrandon
et al.19 reported a new technique for grafting of epithe-
lial sheets onto the dermal surface of a flap to secure a
more compatible wound bed for the epithelial grafts.
Maxillofacial surgical procedures often need to cover
open wounds in the oral mucosa with placement of the
grafts onto the underlying muscular layer or onto the sur-
face of free vascular muscular grafts. The animal model
utilized in our study not only created a protected moist
setting for the EVPOME but also allowed its placement
onto the underlying muscular layer within a subcutaneous
pouch of the SCID mouse, simulating a situation often
seen with intraoral reconstruction procedures.
The AlloDerm portion of the EVPOME showed no ev-
idence of an adverse inflammatory reaction or rapid re-
modeling reaction in the early stages after grafting but,
rather, appeared to act as a biomimetic template that pro-
moted the intradermal migration and infiltration of fibro-
blasts and host cells. Previous studies have shown that
the concurrent grafting of a dermal component aids in en-
hancing the quality, and shortening the time, of wound
healing and of maintaining epithelial renewal.22–25 In ad-
dition, it appears important that a human dermal matrix
retain a basement membrane structure as a scaffold to as-
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sist in the optimal growth and differentiation of ker-
atinocytes.23,26
AlloDerm with epithelium, EVPOME, showed marked
remodeling of the collagenous bundles in comparison
with AlloDerm without epithelium. This eventually pro-
gressed to a point of contracture of the EVPOME at 21
days postgrafting. This may be secondary to the way in
which the EVPOME was secured, without the benefit of
sutures onto a mobile underlying muscular–connective
tissue base. In addition, cultured keratinocytes are capa-
ble of contracting the acellular dermis by secretion of en-
zymes that are initiated by infiltrating mesenchymal fi-
broblastic cells into the underlying dermis via paracrine
pathways.27 Epithelial detachment seen in D4E and the
undulated epithelial layer of D11E, at postgrafting day
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FIG. 8. Immunohistochemical detection of vascularity by in-
growth of mouse endothelial cells after grafting, using WGA
lectin binding. Microvessels can be easily identified by im-
munohistochemical staining for WGA lectin binding whether
erythrocytes are present (arrows) or not present within the lu-
men (arrowheads). (Immunostaining for WGA lectin; original
magnification, 3500; scale bar, 50 mm.)
TABLE 2. MICROVESSEL COUNT WITHIN EVPOME 
OVER TIME AFTER GRAFTINGa
Days postgrafting
3 10 21
Controlb (n 5 5) 1.2 6 0.4 2.6 6 0.4 11.2 6 3.6
D4E (n 5 15) 1.7 6 0.2 15.5 6 5.0c 26.0 6 5.4
D11E (n 5 10) 2.4 6 0.6 69.7 6 7.5c,d 19.2 6 1.9
D18E (n 5 10) 3.0 6 0.2c,d 68.6 6 10.7c,d 28.5 6 5.1c
Abbreviations:D4E, D11E, and D18E: day 4, day 11, and day
18 equivalents, respectively; EVPOME, ex vivo-produced and
oral mucosa equivalent.
aValues represent means 6 SEM.
bAlloDerm without an epithelial layer.
cSignificantly different from control at p , 0.05.
dSignificantly different from D4E at p , 0.05.
21, could be secondary to this cellular process resulting
in dermal contraction.
After the initial 2 to 3 days postgrafting, two pathways
of vascularity determine posttransplantation viability of
the grafted tissue. Vascularity of the free grafts can oc-
cur through inosculation, the “hook up” or anastomosis
of newly ingrown host vessels into preexisting vessels
present in the grafted or transplanted tissue,28,29 or by
neovascularization, the growth of completely new capil-
laries from the recipient bed into the graft. Young and
others29 showed that the initial vascularization of skin
grafts is solely the result of inosculation rather than neo-
vascularization. Blood vessels filled with erythrocytes
were frequently seen within the dermal component, 
AlloDerm, in D11E and D18E at postgrafting day 10.
One of the unique properties of AlloDerm is the reten-
tion of the original, intact blood vessel channels even af-
ter its processing.30 These residual walls and lumens of
the blood vessels within the AlloDerm can act as a tem-
plate or conduit to enhance migration of endothelial cells
to form intact vessels to the EVPOME.30,31 The three-
dimensional network structure of AlloDerm has the ad-
vantage of reestablishing vascular flow within the der-
mis by virtue of both inosculation and neovasculariza-
tion.
Several studies have shown that a dermal substrate in-
fluences growth of keratinocytes.6,26,30,32–34 In our study,
the results demonstrate that the presence of a healthy and
intact epithelial layer on the EVPOME enhanced vascu-
lar infiltration into the underlying dermis when compared
with the control samples, AlloDerm without epithelium,
which showed less fibroblastic infiltration and vessel lu-
men formation (Table 2). In addition, the different pat-
terns of vascular ingrowth seen within the dermal layer
of the three types of EVPOME, D4E, D11E, and D18E,
are thought to be related to the number and stage of dif-
ferentiation of the overlying keratinocytes.
Several studies have shown that vascular endothelial
growth factor (VEGF) secreted by keratinocytes plays a
role in fibrovascular ingrowth.35–37 Viac and others37
showed that VEGF expression in the epithelium could
be modified according to the stage of cell differentiation
and during rapid growth or activation of keratinocytes.
In cultured keratinocytes, the amount of cell-associated
and secreted VEGF increased with time, and was released
extracellularly, after its production (data not shown). The
gradual increase in epithelial stratification and expres-
sion of the epithelial differentiation marker, keratin
10/13, in the suprabasal layer in both D4E and D11E, at
day 21 postgrafting, is consistent with previous reports
that show expression of several differentiation markers
in the suprabasal layer cells of skin composites composed
of acellular dermis after grafting.38,39 Although we did
not examine transplants more than 21 days postgrafting,
it is noteworthy that no keratin 10/13 expression was seen
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within keratinocytes on EVPOME before grafting. The
expression of keratin 10/13 within the epithelial layer be-
came evident only after grafting in situ within SCID mice.
This implied that the epithelial layer of D4E and D11E
possessed a hyperproliferative and long-term replicative
cell population even after transplantation into SCID mice.
The stratified keratinocytes in D4E expressed keratin
10/13 sooner and stronger than in D11E.
In conclusion, the presence of an intact and viable ep-
ithelial layer influenced secondary remodeling within the
dermis of the EVPOME, most likely by its synthesis and
release of cytokines, enzymes, and growth factors. Al-
though the survival and thickness of overlying epithe-
lium, in vivo, depended on the length of time of in vitro
culturing of the EVPOME at an air–liquid interface, it
appears that D11E contained the optimal balance of
revascularity and epithelial activity. The advantage of us-
ing D11E for grafting is its shorter culture period to pro-
duce equivalents 1 week relative to D18E, without com-
promising on epithelial stratification and without a
decrease in fibrovascular ingrowth within the dermis. The
advantage of D11E over D4E is the increased stratifica-
tion of the epithelium seen in D11E, resulting in enhanced
vascularity of the underlying dermal component after
grafting is situ.
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